EPO “Follow-On” Products In Europe Need Two Clinical Efficacy Trials, EMEA Says

European Medicines Agency draft guidance on registration requirements for biosimilar epoetin products says efficacy studies should include a “maintenance phase” and a “titration phase.” The guidelines also call for clinical safety data from at least 300 patients.